Company: TVRD
Filing Date: 2025-03-24
Form Type: 8-K
Source: 0001104659-25-027233
Chunk: 3

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-03-24
Form: 8-K
Item: Item 8.01
Chunk 3
---
us false and misleading.

Between December 18, 2024 and March 24,
2025, Cara received thirteen demands and three draft complaints from purported stockholders of Cara making substantially similar claims
as in the Complaints regarding the disclosures in the proxy statement/prospectus related to the Merger.

Additional lawsuits may be filed against
Cara, Merger Sub, Tvardi, and/or the Cara Board, and additional demands may be received in connection with the Merger and the proxy statement/prospectus.
The defendants dispute the allegations in the shareholder demands and the Complaints.

  The following disclosure replaces the second paragraph under the risk factor titled “ Cara and                                              

Following the Closing, Sujal Shah will
serve as Chairman and Imran Alibhai will serve as the Chief Executive Officer of Cara as the combined company. Additionally, following
the closing, the Combined Company Board will consist of seven directors, and will be comprised of five members designated by Tvardi (Sujal
Shah, Michael Wyzga, Wallace Hall, Shaheen Wirk and Imran Alibhai), one member designated by Cara (Susan Shiff)and one vacancy,
to be designated by Tvardi if prior to the closing of the Merger or by the combined company if following the consummation of the Merger.

  The following disclosure replaces the first paragraph under the risk factor titled “[t]he combined                                    
  company may become involved in securities litigation that could divert management’s attention and harm the combined company’s         
  business and insurance coverage may not be sufficient to cover all costs and damages,” on page 31 of the proxy statement/prospectus:  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

In
the past, securities class action or stockholder derivative litigation often follows certain significant business transactions, such as
the sale of a business division or announcement of a merger. The combined company may become involved in this type of litigation in the
future in connection with the Merger and the other Contemplated Transactions. As of March 24, 2025, t wo lawsuits
were filed in the Supreme Court of the State of New York, County of New York on March 5 and March 6, 2025 by two purported stockholders
of Cara in connection with the Merger. Each Complaint named as defendants Cara and the members of the Cara board of directors. The plaintiffs
contended that the Form 424